PMID- 11224147 OWN - NLM STAT- Publisher LR - 20191120 IS - 1473-5849 (Electronic) IS - 0955-8810 (Linking) VI - 3 IP - 5 DP - 1992 Oct TI - Discriminative stimulus effects of the optical isomers of 3,4-methylenedioxyamphetamine (MDA). PG - 443-454 AB - The isomers of 3,4-methylenedioxyamphetamine (MDA) functioned as discriminative stimuli in rats trained to discriminate either (-) MDA (1.25mg/kg) or (+) MDA (1.25mg/kg) from saline. Dose- and time-response curves indicated that drug lever selection occurred at doses of at least 1.00mg/kg of (-) MDA and 0.75mg/kg of (+) MDA and that drug-appropriate responding for both isomers was maintained for at least 90min. Cross-substitution was observed between the MDA isomers; both (+) and (-) 3,4-methylenedioxymethamphetamine (MDMA) also substituted completely for (+) and (-) MDA. The hallucinogens (+)-lysergic acid diethylamide (LSD) and (+/-)-2,5-dimethoxy-4-methylamphetamine (DOM), substituted for (-) MDA; neither mescaline nor (+) amphetamine or cocaine had (-) MDA-like effects. LSD also substituted for (+) MDA; DOM, mescaline, (+) amphetamine and cocaine failed to have (+) MDA-like effects. The (-) but not the (+) MDA cue was blocked by the 5-HT(2) antagonist pirenpirone; the dopamine (DA) antagonists SCH-23390 and (-) sulpiride had no effect on either the (-) or (+) MDA cues. When animals were trained to discriminate LSD (0.16mg/kg) or (+) amphetamine (1.0mg/kg) from saline, neither (-) MDA nor (+) MDA substituted completely. These results indicate that: (1) the stimulus effects of the isomers of MDA and MDMA are similar; (2) (-) MDA may be more hallucinogenic (or more accurately, LSD- or DOM-like) than (+) MDA; (3) neither (+) nor (-) MDA has potent amphetamine-like effects; and (4) the effects of (-) MDA may be more serotonergic than those of (+) MDA. FAU - Broadbent, J AU - Broadbent J AD - Behavioral Pharmacology Laboratory, Department of Psychology, University of South Carolina, Columbia, SC 29208, USA. FAU - Appel, JB AU - Appel JB FAU - Michael, EK AU - Michael EK FAU - Ricker, JH AU - Ricker JH LA - eng PT - Journal Article PL - England TA - Behav Pharmacol JT - Behavioural pharmacology JID - 9013016 EDAT- 1992/10/01 00:00 MHDA- 2001/02/27 10:00 CRDT- 1992/10/01 00:00 PHST- 1992/10/01 00:00 [pubmed] PHST- 2001/02/27 10:00 [medline] PHST- 1992/10/01 00:00 [entrez] PST - ppublish SO - Behav Pharmacol. 1992 Oct;3(5):443-454.